In vitro neuronal and vascular responses to 5-hydroxytryptamine: Modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine

European Journal of Pharmacology

Volumn 444, Issue 1-2, 2002, Pages 61-67

  Murphy, James E J ^a   Flynn, James J ^a   Cannon, Dara M ^a   Guiry, Patrick J ^a   McCormack, Peter ^a   Baird, Alan W ^a   McBean, Gethin J ^a   Keenan, Alan K ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

4 MTA (4 methylthioamphetamine); 4 MTMA (4 methylthiomethamphetamine); 5 HT (5 hydroxyhyptamine, serotonin); Aortic contraction; MDMA (3,4 methylenedioxymethamphetamine); Reuptake; Synaptosome

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 METHYLTHIOAMPHETAMINE; 4 METHYLTHIOMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; SEROTONIN; UNCLASSIFIED DRUG; 4-METHYLTHIOAMPHETAMINE; SEROTONIN UPTAKE INHIBITOR;

ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN SYNAPTOSOME; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MISUSE; IC 50; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN UPTAKE; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; METABOLISM; SYNAPTOSOME; VASCULAR SMOOTH MUSCLE; WISTAR RAT;

AMPHETAMINES; ANIMAL; BRAIN; MUSCLE, SMOOTH, VASCULAR; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SUPPORT, NON-U.S. GOV'T; SYNAPTOSOMES; ANIMALS;

EID: 0037165825     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01586-8     Document Type: Article

References (32)

1. Centrally acting N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine)
2. Cardiovascular autonomic dysregulation in users of MDMA ("Ecstasy")
3. Reduction of b-nitrostyrenes with sodium bis(-2-methoxyethoxy)-aluminium dihydride: A convenient route to substituted phenylisopropylamines
4. In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA
5. Stereochemical differences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro: A pharmacokinetic analysis
6. Para-methylthioamphetamine, a new amphetamine designer drug of abuse
7. 'Eve' and 'Ecstasy.' A report of five deaths associated with the use of MDEA and MDMA
8. A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: Homogeneity and morphology of subcellular fractions
9. Fatal poisoning with a new phenylethylamine: 4-methylthioamphetamine (4-MTA)
10. 2A receptor signal transduction
11. Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat
12. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or 'Ecstasy')
13. The identification of 4-methylthioamphetamine in a drug seizure
14. MDMA. The dark side of ecstasy
15. 5-Hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents
16. P-Methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent
17. 3H]Monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues
18. Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAI) and p-methylthioamphetamine (MTA)
19. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
20. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans
21. Pathology of deaths associated with "ecstasy" and "eve" misuse
22. 2C receptors
23. Analytical profile of 4-methylthioamphetamine (4-MTA), a new street drug
24. Neurochemical neutralisation of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: A pharmacological strategy for treating stimulant abuse
25. P-Chloroamphetamine induces serotonin release through serotonin transporters
26. Distribution and excretion of methamphetamine and its metabolites in rats: II. Time course of concentration in blood and distribution after multiple oral administration
27. Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action
28. 3H]monoamines into synaptosomes from different regions of rat brain
29. A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives
30. "Ecstasy" and sudden cardiac death
31. Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naive healthy volunteers